Akanda (AKAN) Change in Receivables (2021 - 2025)
Akanda (AKAN) recorded quarterly Change in Receivables of $4097.0 in Q2 2025, down 98.89% quarter-over-quarter from $370537.0 in Q4 2024, and down 98.69% on a YoY basis from $311721.0 in Q2 2024.
Akanda (AKAN) Change in Receivables (2021 - 2025) Analysis & Trends
Akanda's Change in Receivables history runs 5 years deep, the most recent figure standing at $4097.0 for Q2 2025.
- In Q2 2025, Change in Receivables fell 98.69% year-over-year to $4097.0; the TTM figure through Jun 2025 stood at $4097.0 (down 98.69% YoY), while the FY2024 annual figure was $370537.0, up 30.24% from the prior year.
- Change in Receivables was $4097.0 for Q2 2025 at Akanda, down from $370537.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.2 million in Q4 2022 to a low of $4097.0 in Q2 2025.
- Historically, Change in Receivables has averaged $479159.6 across 5 years, with a median of $341129.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables soared 409.83% in 2022, then plunged 98.69% in 2025.
- A 5-year view of Change in Receivables shows it stood at $242357.0 in 2021, then jumped by 409.83% to $1.2 million in 2022, then sank by 76.97% to $284513.0 in 2023, then soared by 30.24% to $370537.0 in 2024, then slumped by 98.89% to $4097.0 in 2025.
- The last three Change in Receivables figures came in at $4097.0 (Q2 2025), $370537.0 (Q4 2024), and $311721.0 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Akanda | 826.99 Mn | 824.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4,097.00 |
| Jun 30, 2025 | 4,097.00 |
| Dec 31, 2024 | 370,537.00 |
| Dec 31, 2024 | 370,537.00 |
| Jun 30, 2024 | 311,721.00 |
| Jun 30, 2024 | 311,721.00 |
| Dec 31, 2023 | 284,513.00 |
| Dec 31, 2023 | 284,513.00 |
| Jun 30, 2023 | 657,568.00 |
| Jun 30, 2023 | 657,568.00 |
| Dec 31, 2022 | 1.24 Mn |
| Dec 31, 2022 | 1.24 Mn |
| Jun 30, 2022 | 726,865.00 |
| Jun 30, 2022 | 726,865.00 |
| Dec 31, 2021 | 242,357.00 |
| Dec 31, 2021 | 242,357.00 |